Sotac Pharmaceuticals Concludes EGM to Increase Authorised Share Capital
Sotac Pharmaceuticals Ltd · Annual General Meeting · 31 Oct 2026, 9:38 pm
Sotac Pharmaceuticals Concludes EGM to Increase Authorised Share Capital Sotac Pharmaceuticals held its Extra-Ordinary General Meeting on 31st Oct'26 to seek shareholder approval for increasing its Authorised Share Capital from ₹11.50 cr to ₹15.00 cr. The expansion involves creating an additional 35,00,000 equity shares of ₹10 each, aggregating to ₹3.50 cr, alongside consequential alterations to Clause V of its Memorandum of Association. The capital expansion aims to enhance financial flexibility to meet future capital requirements and fund growth initiatives. Consolidated voting results scrutinized by Mittal V. Kothari & Associates will be declared within two working days.
Original exchange filing (PDF)
More announcements from Sotac Pharmaceuticals Ltd
- Sotac Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 13 Nov 2026
- Sotac Pharmaceuticals Limited has informed the Exchange about General Updates regarding Clarification in price movement. · 05 Nov 2026
- Significant movement in price has been observed in Sotac Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. · 03 Nov 2026
- Sotac Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 13 Nov 2026
- Sotac Pharmaceuticals Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company. · 03 Nov 2026
- Sotac Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on October 31, 2026. Further, the company has informed the Exchange regarding voting results. · 02 Nov 2026
- Sotac Pharmaceuticals Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on October 31, 2026 · 08 Oct 2026
